Načítá se...
Pharmacoproteomic characterisation of human colon and rectal cancer
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models for proteome‐guided pre‐clinical drug sensitivity studies are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of > 1...
Uloženo v:
| Vydáno v: | Mol Syst Biol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731344/ https://ncbi.nlm.nih.gov/pubmed/29101300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/msb.20177701 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|